Dr. Meliambro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Pl
New York, NY 10029Phone+1 212-987-7208
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 2012 - 2014
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2012
- Icahn School of Medicine at Mount SinaiClass of 2009
Certifications & Licensure
- NY State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 68 citationsPodocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal FailureMonica Schwartzman, Antoine Reginensi, Jenny Wong, John M. Basgen, Kristin Meliambro
Journal of the American Society of Nephrology. 2016-01-01 - 28 citationsThe Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.Kristin Meliambro, Jenny Wong, Justina Ray, Rhodora Cristina Calizo, Sara Towne
The Journal of Biological Chemistry. 2017-12-22 - 5 citationsPodocyte-targeted therapies - progress and future directions.Kristin Meliambro, John C He, Kirk N Campbell
Nature Reviews. Nephrology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: